[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100545448":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":47,"collaborators":18,"id":49,"slug":18,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":18,"enrollmentInfo":58,"targetDuration":18,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":69,"overallStatus":70,"whyStopped":18,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Navy General Hospital, Beijing","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"mVTEA Management Group","EXPERIMENTAL","Patients randomly assigned to the mVTEA management group will be discharged with mVTEA-assisted patient-centered PTE management.",[13],"Other: mobile venous thromboembolism application (mVTEA)",{"label":15,"type":16,"description":17,"interventionNames":18},"Routine Management Group","NO_INTERVENTION","Patients randomly assigned to the routine management group will be given routine post-discharge management in accordance with local clinical practice.",null,[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":18},"mobile venous thromboembolism application (mVTEA)","mVTEA will assist in the management of patients during the post-hospitalization follow-up phase. The mVTEA's doctor terminal automatically sends venous thromboembolism (VTE)-related health education materials in different frequencies and contents based on the patient's knowledge of VTE prevention and treatment, as well as their risk of thrombosis and bleeding during follow-up. In addition, thrombosis physicians on the mVTEA's doctor terminal can deliver health education to patients based on their condition. This can be done through the mVTEA doctor-patient communication module, which includes text, voice, and video communication.",[9],[25],{"name":26,"affiliation":27,"role":28},"YU-TAO GUO, Doctor","Sixth Medical Center of Chinese PLA General Hospital","STUDY_CHAIR",[30],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"ZHI-GENG JIN, Doctor","CONTACT","8615801402223","lwgjzg@163.com",[36],{"facility":27,"status":18,"city":37,"state":38,"zip":39,"country":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":18},"Beijing","Beijing Municipality","100048","China",{"type":42,"coordinates":43},"Point",[44,45],116.39723,39.9075,{"lat":45,"lon":44},{"type":48,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100545448",false,"NCT06382038","Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism","Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism：A Multicenter, Randomized Controlled Trial","SmaPE","Inclusion Criteria:\n\n* Inpatients aged ≥18 years;\n* （2）PTE confirmed through imaging examinations, meeting at least one of the following criteria: a.Newly diagnosed PTE during the current hospitalization; b. Prior PTE with imaging evidence of residual thrombus.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Previous PTE combined with CTEPH;\n* Mental retardation or a combination of other serious illnesses that make them incapable of living on their own;\n* Inability to use smartphones, computer tablets and other smart devices;\n* Being pregnant or breastfeeding;\n* Have participated in similar trials or are undergoing other clinical trials.","ALL","18 Years",{"count":59,"type":60},2972,"ESTIMATED","INTERVENTIONAL",[63],"NA","Smart technologies, such as wearable devices, mobile technologies, and artificial intelligence, are being investigated for use in health management. These technologies have the potential to be applied in disease pre-warning, decision-making support, health education, and healthcare maintenance. They are expected to address the challenges in managing thrombosis, improve access to high-quality medical resources in various regions, and enhance the development of a network for thrombosis rescue and treatment prevention.\n\nThe objective of this study is to evaluate the impact of mobile venous thromboembolism application (mVTEA) based patient-centered management of pulmonary thromboembolism (PTE) on the long-term outcome of PTE patients, in order to enhance clinical practice and establish a foundation of evidence for managing patients with PTE.",[66,67,68],"Venous Thromboembolism","Pulmonary Thromboembolisms","Digital Health",[66,67,68],"NOT_YET_RECRUITING","2025-05-27",{"date":73,"type":74},"2025-05-31","ACTUAL",{"date":76,"type":60},"2025-10-08",{"date":78,"type":60},"2026-10-31",{"name":5,"class":6},1]